Form 4: GE HealthCare CFO Saccaro's RSU Tax Withholding

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro reported the disposition of shares to cover tax obligations from restricted stock unit vesting.

Summary

• James Saccaro, Chief Financial Officer of GE HealthCare Technologies Inc., reported transactions involving the company's common stock.
• On September 1, 2025, a total of 3,238 shares of common stock were disposed of in two separate transactions (1,740 shares and 1,498 shares).
• These dispositions were made to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• The shares were disposed of at a price of $73.73 per share.
• Following these transactions, James Saccaro beneficially owns 58,594 shares of GE HealthCare Technologies Inc. common stock.
• The transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction for tax purposes related to RSU vesting, which is a common and expected event in executive compensation. It does not indicate a change in company fundamentals or strategic direction.

Positives

• The underlying event is the vesting of restricted stock units, indicating the executive is being compensated and retaining a significant equity stake in the company.

Negatives

• The disposition of shares, even for tax purposes, results in a reduction of the Chief Financial Officer's direct ownership stake in the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This filing is a routine insider transaction report specific to GE HealthCare Technologies Inc. and its Chief Financial Officer, and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Minimal direct impact, as this is a routine executive compensation event and does not reflect a change in company strategy or financial health.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates

Keywords

GE HealthCare Technologies, GEHC, James Saccaro, CFO, Form 4, Insider Transaction, Restricted Stock Units, RSU, Tax Withholding, Equity Compensation, 10b5-1 Plan